Combined protein and calcium β-hydroxy-β-methylbutyrate induced gains in leg fat free mass: a double-blinded, placebo-controlled study.


Journal

Journal of the International Society of Sports Nutrition
ISSN: 1550-2783
Titre abrégé: J Int Soc Sports Nutr
Pays: United States
ID NLM: 101234168

Informations de publication

Date de publication:
12 Mar 2020
Historique:
received: 16 08 2019
accepted: 13 01 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 31 3 2020
Statut: epublish

Résumé

The leucine metabolite β-hydroxy-β-methylbutyrate (HMB) is widely used as an ergogenic supplement to increase resistance-training induced gains in fat free mass (FFM) and strength in healthy adults. Recent studies have questioned the effectiveness of HMB, particularly when a high protein diet is habitually consumed. To investigate the additive resistance-training induced effects of HMB and protein in untrained individuals, we conducted a randomized double-blind, placebo-controlled study that compared the effects of combined protein and HMB supplementation to protein supplementation alone on FFM and muscle strength after 12-week resistance training. Sixteen healthy men (22 ± 2 yrs) performed a periodized resistance-training program for twelve weeks (four sessions per week). The program comprised two mesocycles, characterized by a linear periodization and non-linear periodization, respectively, and separated by a 1-week tapering period. All participants received 60 g of whey protein on training days and 30 g of whey protein (WP) on non-training days. Participants were randomly assigned to additionally receive 3 g of calcium HMB (WP + HMB) or a placebo (WP + PLA). Body composition and physical fitness were tested before and after the 12-week training program. Whole-body and arm and leg fat free mass (FFM) were assessed by bioimpedance spectroscopy; upper arm and leg fat free cross sectional areas were also quantified using magnetic resonance imaging (MRI); upper and lower body strength were measured by One-repetition maximum (1-RM) bench press and leg press. Whole-body and segmental FFM increased in both groups (P <  0.001). However, gains in leg FFM were higher in WP + HMB vs. WP + PLA (arm FFM: + 6.1% vs. + 9.2%, P = 0.2; leg FFM: + 14.2% vs. + 7.0%, P <  0.01). No change in fat mass was observed (P = 0.59). 1-RM increased in both groups (P <  0.001). Combined protein and HMB supplementation resulted in segmental, but not whole-body increases in FFM compared to protein supplementation alone. These findings could explain some of the controversial effects of HMB reported in previous studies and have practical implications for maximizing training-induced gains in FFM and clinical conditions associated with skeletal muscle deconditioning such as aging, sedentary lifestyles, bed rest and spaceflight.

Sections du résumé

BACKGROUND BACKGROUND
The leucine metabolite β-hydroxy-β-methylbutyrate (HMB) is widely used as an ergogenic supplement to increase resistance-training induced gains in fat free mass (FFM) and strength in healthy adults. Recent studies have questioned the effectiveness of HMB, particularly when a high protein diet is habitually consumed. To investigate the additive resistance-training induced effects of HMB and protein in untrained individuals, we conducted a randomized double-blind, placebo-controlled study that compared the effects of combined protein and HMB supplementation to protein supplementation alone on FFM and muscle strength after 12-week resistance training.
METHODS METHODS
Sixteen healthy men (22 ± 2 yrs) performed a periodized resistance-training program for twelve weeks (four sessions per week). The program comprised two mesocycles, characterized by a linear periodization and non-linear periodization, respectively, and separated by a 1-week tapering period. All participants received 60 g of whey protein on training days and 30 g of whey protein (WP) on non-training days. Participants were randomly assigned to additionally receive 3 g of calcium HMB (WP + HMB) or a placebo (WP + PLA). Body composition and physical fitness were tested before and after the 12-week training program. Whole-body and arm and leg fat free mass (FFM) were assessed by bioimpedance spectroscopy; upper arm and leg fat free cross sectional areas were also quantified using magnetic resonance imaging (MRI); upper and lower body strength were measured by One-repetition maximum (1-RM) bench press and leg press.
RESULTS RESULTS
Whole-body and segmental FFM increased in both groups (P <  0.001). However, gains in leg FFM were higher in WP + HMB vs. WP + PLA (arm FFM: + 6.1% vs. + 9.2%, P = 0.2; leg FFM: + 14.2% vs. + 7.0%, P <  0.01). No change in fat mass was observed (P = 0.59). 1-RM increased in both groups (P <  0.001).
CONCLUSIONS CONCLUSIONS
Combined protein and HMB supplementation resulted in segmental, but not whole-body increases in FFM compared to protein supplementation alone. These findings could explain some of the controversial effects of HMB reported in previous studies and have practical implications for maximizing training-induced gains in FFM and clinical conditions associated with skeletal muscle deconditioning such as aging, sedentary lifestyles, bed rest and spaceflight.

Identifiants

pubmed: 32164702
doi: 10.1186/s12970-020-0336-1
pii: 10.1186/s12970-020-0336-1
pmc: PMC7069016
doi:

Substances chimiques

Performance-Enhancing Substances 0
Valerates 0
Whey Proteins 0
beta-hydroxyisovaleric acid 3F752311CD
Calcium SY7Q814VUP

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

16

Références

J Strength Cond Res. 2010 Feb;24(2):531-7
pubmed: 20072045
Nutr Metab (Lond). 2008 Jan 03;5:1
pubmed: 18173841
J Int Soc Sports Nutr. 2014 Apr 26;11:16
pubmed: 24782684
J Strength Cond Res. 2004 Nov;18(4):747-52
pubmed: 15574078
Physiol Meas. 2008 Feb;29(2):193-203
pubmed: 18256451
J Appl Physiol (1985). 2007 Oct;103(4):1428-35
pubmed: 17626831
J Am Coll Nutr. 2015;34(2):91-9
pubmed: 25758255
J Int Soc Sports Nutr. 2016 Feb 29;13:7
pubmed: 26933398
J Sports Med Phys Fitness. 2003 Mar;43(1):64-8
pubmed: 12629464
J Int Soc Sports Nutr. 2013 Feb 02;10(1):6
pubmed: 23374455
Am J Clin Nutr. 1995 Jun;61(6):1179-85
pubmed: 7762515
Sports Med. 2000 Aug;30(2):105-16
pubmed: 10966150
Med Sci Sports Exerc. 2019 Jan;51(1):56-64
pubmed: 30102677
Int J Sport Nutr Exerc Metab. 2007 Feb;17(1):56-69
pubmed: 17469236
Med Sci Sports Exerc. 2019 Jan;51(1):65-74
pubmed: 30113522
Physiol Meas. 2006 Sep;27(9):921-33
pubmed: 16868355
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):529-541
pubmed: 28493406
J Int Soc Sports Nutr. 2015 Jul 30;12:31
pubmed: 26225130
J Strength Cond Res. 2001 Nov;15(4):491-7
pubmed: 11726262
Int J Sport Nutr Exerc Metab. 2019 Sep 1;29(5):505-511
pubmed: 30859862
Nutrients. 2017 Dec 02;9(12):
pubmed: 29207472
Am J Physiol. 1992 Jan;262(1 Pt 1):E27-31
pubmed: 1733247
Am J Hum Biol. 1997;9(1):63-72
pubmed: 28561481
J Appl Physiol (1985). 1996 Nov;81(5):2095-104
pubmed: 8941534
Scand J Med Sci Sports. 2018 Mar;28(3):846-853
pubmed: 28805932
Med Sci Sports Exerc. 2009 May;41(5):1111-21
pubmed: 19346975
J Appl Physiol (1985). 2005 Aug;99(2):780-1
pubmed: 16020450
Int J Sport Nutr Exerc Metab. 2001 Sep;11(3):384-96
pubmed: 11599506
J Appl Physiol (1985). 1999 Jan;86(1):195-201
pubmed: 9887131
Int J Sports Med. 1999 Nov;20(8):503-9
pubmed: 10606212
Food Funct. 2018 Sep 19;9(9):4836-4846
pubmed: 30137075
Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1423-31
pubmed: 15886351
J Strength Cond Res. 2016 Jul;30(7):1843-54
pubmed: 24714541
Med Sci Sports Exerc. 2000 Dec;32(12):2109-15
pubmed: 11128859
Nutr Metab (Lond). 2009 Feb 04;6:6
pubmed: 19193206
Eur J Appl Physiol. 2014 Jun;114(6):1217-27
pubmed: 24599749
J Appl Physiol (1985). 1997 May;82(5):1542-58
pubmed: 9134904
J Appl Physiol (1985). 1994 Jul;77(1):98-112
pubmed: 7961281
Mol Aspects Med. 2016 Aug;50:56-87
pubmed: 27106402
Br J Sports Med. 2018 Mar;52(6):376-384
pubmed: 28698222
J Sci Med Sport. 2018 Jul;21(7):727-735
pubmed: 29249685

Auteurs

Alexander C Stahn (AC)

Research Section for Behavioral Regulation and Health, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, 1016 Blockley Hall, 423 Guardian Drive, 19104, Philadelphia, USA. astahn@pennmedicine.upenn.edu.
Charité - Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Berlin, 10117, Germany. astahn@pennmedicine.upenn.edu.

Martina Anna Maggioni (MA)

Charité - Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Berlin, 10117, Germany.
Department of Biomedical Sciences for Health, Università degli Studi di Milano, via G. Colombo 71, 20133, Milan, Italy.

Hanns-Christian Gunga (HC)

Charité - Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Berlin, 10117, Germany.

Elmarie Terblanche (E)

Department of Sport Science, University of Stellenbosch, Private Bag X1, Matieland, 7602, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH